Dr MeiLan Han, of the University of Michigan, Ann Arbor, highlights studies in chronic obstructive pulmonary disease (COPD) presented at the CHEST 2021 Annual Meeting. Dr Han first reports on a study ...

Inhalers Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations. Single-inhaler ...

CHEST efforts lead to a CMS proposal that includes substantial changes to federal coverage guidelines for NIV devices used in the home.

Eosinophil Granulocytes COPD Patients with COPD who exhibit low blood eosinophil counts had no change in exacerbations or survival compared with patients with typical counts. Patients with chronic ...

Christopher Carlin, MBChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.

In patients with chronic obstructive pulmonary disease (COPD), the use of statins was not associated with a reduced risk of exacerbation. Findings suggest that statins should not be prescribed in ...

Many people with chronic obstructive pulmonary disease (COPD) experience severe fatigue that can limit their ability to perform daily activities. A 2021 review found fatigue was a symptom of COPD in ...

- Data presented show maintained or improved responses in multiple efficacy endpoints among patients treated with sotatercept plus stable background therapy for up to 48 weeks - - Patients receiving ...

Please provide your email address to receive an email when new articles are posted on . The FDA found that AstraZeneca made misleading claims about Breztri Aerosphere for COPD in sales material. These ...